In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is ...

Treatment with tirzepatide reduced the risk of heart failure outcomes – specifically a heart failure urgent visit or hospitalisation, oral diuretic intensification, or cardiovascular death ...

Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials.